ArticleMethods in molecular biology (Clifton, N.J.)2026

MHC II MAPPs for High-Confident Immunogenicity Risk Assessment of Biotherapeutics.

Elise Pepermans et al.PubMed ↗Publisher ↗

No numbers read from the abstract.